XenoTherapeutics is a not-for-profit, clinical-stage regenerative medicine company developing innovative cell and tissue-based research solutions. Our FDA-accepted pathogen screening and validated assays provide a robust regulatory pathway for the clinical advancement of xenogeneic cells, tissues, and organs. We accelerate the development, testing, training, and commercialization of innovative, live biotherapeutic products that deliver on the promise of regenerative medicine.
View Top Employees from XenoTherapeutics| Website | http://www.xenotx.org |
| Revenue | $344000 |
| Employees | 6 (6 on RocketReach) |
| Founded | 2016 |
| Address | 359 Newbury Street 5th Floor, Boston, Massachusetts 02115, US |
| Phone | +61 79397892 |
| Technologies |
JavaScript,
HTML,
Twitter
+12 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Medical Device, Pharmaceuticals, Health Care, Healthcare |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies |
Looking for a particular XenoTherapeutics employee's phone or email?
XenoTherapeutics Questions
The XenoTherapeutics annual revenue was $344000 in 2024.
6 people are employed at XenoTherapeutics.
XenoTherapeutics is based in Boston, Massachusetts.
The NAICS codes for XenoTherapeutics are [5417, 541, 54171, 54, 541714].
The SIC codes for XenoTherapeutics are [873, 87].
Top XenoTherapeutics Employees
-
1
-
ViewMark Steffen
Senior Public Affairs and Media Relations Officer at XenoTherapeutics
Cambridge, Massachusetts, United States11 -
1
-
Related Companies
